Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2484.65 and 2555.45
| Intraday Target 1 | 2427.57 |
| Intraday Target 2 | 2470.93 |
| Intraday Target 3 | 2498.3666666667 |
| Intraday Target 4 | 2541.73 |
| Intraday Target 5 | 2569.17 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 24 July 2026 | 2514.30 (0.77%) | 2490.20 | 2455.00 - 2525.80 | 0.8679 times | Thu 23 July 2026 | 2495.00 (-2.26%) | 2560.00 | 2490.00 - 2570.00 | 0.8295 times | Wed 22 July 2026 | 2552.80 (1.84%) | 2498.90 | 2462.20 - 2562.80 | 1.3897 times | Tue 21 July 2026 | 2506.60 (0.95%) | 2475.00 | 2465.20 - 2510.00 | 0.5644 times | Mon 20 July 2026 | 2483.10 (1.15%) | 2454.50 | 2445.40 - 2500.00 | 0.7739 times | Fri 17 July 2026 | 2454.80 (-2.05%) | 2506.30 | 2430.00 - 2510.60 | 0.764 times | Thu 16 July 2026 | 2506.30 (0.91%) | 2477.10 | 2466.20 - 2512.00 | 1.1241 times | Wed 15 July 2026 | 2483.70 (0.82%) | 2476.00 | 2451.20 - 2500.90 | 0.6681 times | Tue 14 July 2026 | 2463.40 (1.77%) | 2420.50 | 2418.30 - 2527.00 | 2.5429 times | Mon 13 July 2026 | 2420.50 (-0.73%) | 2439.90 | 2406.30 - 2439.90 | 0.4755 times | Fri 10 July 2026 | 2438.20 (-0.09%) | 2441.00 | 2423.50 - 2453.80 | 0.2952 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2479.85 and 2604.45
| Weekly Target 1 | 2385.3 |
| Weekly Target 2 | 2449.8 |
| Weekly Target 3 | 2509.9 |
| Weekly Target 4 | 2574.4 |
| Weekly Target 5 | 2634.5 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 24 July 2026 | 2514.30 (2.42%) | 2454.50 | 2445.40 - 2570.00 | 0.5812 times | Fri 17 July 2026 | 2454.80 (0.68%) | 2439.90 | 2406.30 - 2527.00 | 0.7321 times | Fri 10 July 2026 | 2438.20 (1.78%) | 2390.20 | 2370.00 - 2460.80 | 0.5188 times | Fri 03 July 2026 | 2395.50 (1.73%) | 2347.80 | 2335.40 - 2504.70 | 1.1328 times | Thu 25 June 2026 | 2354.80 (0.98%) | 2358.10 | 2322.30 - 2404.80 | 0.838 times | Fri 19 June 2026 | 2332.00 (9.92%) | 2135.10 | 2111.00 - 2350.00 | 1.9115 times | Fri 12 June 2026 | 2121.50 (-1.97%) | 2154.70 | 2088.10 - 2216.00 | 1.4901 times | Fri 05 June 2026 | 2164.10 (-2.09%) | 2200.00 | 2154.00 - 2219.90 | 0.5267 times | Fri 29 May 2026 | 2210.20 (-4.19%) | 2329.00 | 2194.40 - 2341.00 | 1.3418 times | Fri 22 May 2026 | 2306.90 (-5.41%) | 2438.80 | 2297.00 - 2440.00 | 0.927 times | Fri 15 May 2026 | 2438.80 (-1.54%) | 2476.90 | 2400.00 - 2520.00 | 0.6362 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2442.15 and 2642.15
| Monthly Target 1 | 2284.77 |
| Monthly Target 2 | 2399.53 |
| Monthly Target 3 | 2484.7666666667 |
| Monthly Target 4 | 2599.53 |
| Monthly Target 5 | 2684.77 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 24 July 2026 | 2514.30 (2.61%) | 2476.80 | 2370.00 - 2570.00 | 0.7533 times | Tue 30 June 2026 | 2450.30 (10.86%) | 2200.00 | 2088.10 - 2460.90 | 1.7942 times | Fri 29 May 2026 | 2210.20 (-5.4%) | 2342.00 | 2194.40 - 2520.00 | 1.2431 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.7657 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.617 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.9003 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8042 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.3143 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.0962 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7118 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.1339 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2301.2 and 2932.9
| Yearly Target 1 | 1809.03 |
| Yearly Target 2 | 2161.67 |
| Yearly Target 3 | 2440.7333333333 |
| Yearly Target 4 | 2793.37 |
| Yearly Target 5 | 3072.43 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 24 July 2026 | 2514.30 (1.65%) | 2476.00 | 2088.10 - 2719.80 | 0.6292 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.5426 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.1617 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2017 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.698 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.931 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.039 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4444 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.226 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1264 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1267 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 2479.6 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 70 as on Fri 24 July 2026
This Munafa value indicates that the stock is moving upwards and might continue to move up.
SMA20 is at 2453 and price is deviating by 48 points
Upper Bollinger band is at 2549 and lower is at 2358, while middle bands are at 2406 and 2501
Price is rising
Price is above 20day SMA
Price is in upper range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
GlaxosmithklinePharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2490.31 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2510.36 |
| 12 day DMA | 2479.93 |
| 20 day DMA | 2452.97 |
| 35 day DMA | 2360.17 |
| 50 day DMA | 2340.9 |
| 100 day DMA | 2381.71 |
| 150 day DMA | 2412.99 |
| 200 day DMA | 2463.4 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2506.43 | 2502.49 | 2506.24 |
| 12 day EMA | 2479.61 | 2473.3 | 2469.36 |
| 20 day EMA | 2449.22 | 2442.37 | 2436.83 |
| 35 day EMA | 2410.56 | 2404.45 | 2399.12 |
| 50 day EMA | 2366.83 | 2360.81 | 2355.33 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2510.36 | 2498.46 | 2500.72 |
| 12 day SMA | 2479.93 | 2471.3 | 2463.93 |
| 20 day SMA | 2452.97 | 2444.99 | 2438.57 |
| 35 day SMA | 2360.17 | 2350.24 | 2341.27 |
| 50 day SMA | 2340.9 | 2338.84 | 2337.92 |
| 100 day SMA | 2381.71 | 2382.74 | 2384.18 |
| 150 day SMA | 2412.99 | 2413.56 | 2414.41 |
| 200 day SMA | 2463.4 | 2464.12 | 2464.96 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 61.15 and PE is: 41.12
Last quarter profit: (March 2026 quarter) 277.86 crores (5.70%)
Debt: 33.27 in crores
Market capitalization: 39891.73
EPS is 60.27 and PE is: 41.72
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
